Skip to Main Content

Paper Details

Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update.
Crit Care Med
243
2021
Adults, COVID-19, Coronavirus Diease, Coronavirus Disease, Sepsis, convalescent plasma, coronavirus disease, corticosteroids, critical coronavirus disease, dexamethasone, healthcare, hydroxychloroquine, patients, remdesivir
Author NameAffiliation
Laura EvansUniversity of Washington
Marlies OstermannKing's College London, Guy's & St Thomas' Hospital
Yaseen M ArabiKing Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center
Bin DuPeking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences
Hannah Wunsch
Hannah WunschUniversity of Toronto
Maurizio CecconiHumanitas Clinical and Research Center-IRCCS
Maurizio CecconiHumanitas University
Lisa BurryLeslie Dan Faculty of Pharmacy, University of Toronto
Daniel S ChertowNational Institutes of Health Clinical Center and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases
Jozef KeseciogluUniversity Medical Center Utrecht, Utrecht University
Manoj J MammenJacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo
Ruth KleinpellVanderbilt University School of Nursing, TN and Rush University College of Nursing
Naomi HammondThe George Institute for Global Health and UNSW
Naomi HammondRoyal North Shore Hospital
Greg S MartinEmory University School of Medicine and Grady Memorial Hospital
Lewis J KaplanPerelman School of Medicine, University of Pennsylvania Department of Surgery Division of Traumatology
Craig M CoopersmithEmory University School of Medicine
  • 1 - 18

Datasets